Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients

Stergios Lazarinis1, Nils P Hailer1, Josef D Järhult2

  • 1Department of Surgical Sciences, Orthopaedics, Uppsala University, SE-751 85 Uppsala, Sweden.

PubMed
Abstract

Insights

Rifampicin resistance in periprosthetic joint infections (PJI) did not increase, but resistant bacteria raise treatment failure risk over fourfold. Limiting resistance is crucial for effective PJI management.

Area of Science:

  • Infectious Diseases
  • Orthopedic Surgery
  • Microbiology

Background:

  • Rifampicin is essential for treating periprosthetic joint infection (PJI).
  • Increasing rifampicin resistance poses a significant challenge to PJI treatment efficacy.
  • Understanding resistance trends and outcomes is vital for optimizing PJI management.

Purpose of the Study:

  • To investigate the incidence of rifampicin-resistant bacteria in PJI over two decades.
  • To analyze the association between rifampicin resistance and infection-free survival in PJI patients.
  • To evaluate the impact of rifampicin resistance on treatment failure rates.

Main Methods:

  • Retrospective analysis of 238 staphylococcal PJI cases (2001-2020) with available rifampicin susceptibility data.
  • Kaplan-Meier survival analysis to assess infection-free survival.
  • Cox regression modeling to determine adjusted hazard ratios for treatment failure.

Main Results:

  • Rifampicin-resistant bacteria were found in 17% of cases.
  • The proportion of resistant strains decreased from 24% (2010-2015) to 12% (2016-2020).
  • Patients with rifampicin-resistant PJI had a 4.2-fold increased risk of treatment failure and lower 2-year infection-free survival (78.6% vs. 90.0%).

Conclusions:

  • The incidence of rifampicin-resistant PJI has not increased over the past 20 years.
  • Rifampicin-resistant bacteria significantly increase the risk of treatment failure in PJI.
  • Strategies to limit the development of rifampicin resistance are essential for successful PJI treatment.

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.9K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
15
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
17